Jaguar Health, Inc. ( JAGX) - Stock Earnings
JAGX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
JAGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -23.1 million USD | 3.2 million USD |
| 2026Q1 | 8.6 million USD | 20.3 million USD |
| 2026Q2 | -12.7 million USD | 1.2 million USD |
| 2026Q4 Est. | — | — |
JAGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.3 million USD | 9.8 million USD |
| 2024 | -38.5 million USD | 11.7 million USD |
| 2025 | -53.4 million USD | 11.5 million USD |
| 2026 Est. | — | — |
JAGX
Price: $3.52
Earnings Per Share: -739.43 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 617552
Ebitda: -16.5 millionMarket Capitalization: 1.6 million